These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 27525669
1. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma. Qiu GP, Liu J. Genet Test Mol Biomarkers; 2016 Oct; 20(10):579-586. PubMed ID: 27525669 [Abstract] [Full Text] [Related]
2. Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population. Farokhizadeh Z, Dehbidi S, Geramizadeh B, Yaghobi R, Malekhosseini SA, Behmanesh M, Sanati MH, Afshari A, Moravej A, Karimi MH. Ann Lab Med; 2019 Jan; 39(1):58-66. PubMed ID: 30215231 [Abstract] [Full Text] [Related]
3. Predictive role of miR-146a rs2910164 (C>G), miR-149 rs2292832 (T>C), miR-196a2 rs11614913 (T>C) and miR-499 rs3746444 (T>C) in the development of hepatocellular carcinoma. Yan P, Xia M, Gao F, Tang G, Zeng H, Yang S, Zhou H, Ding D, Gong L. Int J Clin Exp Pathol; 2015 Jan; 8(11):15177-83. PubMed ID: 26823863 [Abstract] [Full Text] [Related]
4. Functional miR-146a, miR-149, miR-196a2 and miR-499 polymorphisms and the susceptibility to hepatocellular carcinoma: An updated meta-analysis. Zheng L, Zhuang C, Zhao J, Ming L. Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):664-676. PubMed ID: 28499985 [Abstract] [Full Text] [Related]
5. Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma. Li X, Li K, Wu Z. Int J Clin Exp Pathol; 2015 Dec; 8(8):9560-6. PubMed ID: 26464719 [Abstract] [Full Text] [Related]
6. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis. Yu JY, Hu F, Du W, Ma XL, Yuan K. J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097 [Abstract] [Full Text] [Related]
9. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients. Fteah AM, Ahmed AI, Mosaad NA, Hassan MM, Mahmoud SH. Asian Pac J Cancer Prev; 2019 Nov 01; 20(11):3479-3485. PubMed ID: 31759375 [Abstract] [Full Text] [Related]
11. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization. Wang XC, Wang F, Quan QQ. Genet Test Mol Biomarkers; 2016 Apr 01; 20(4):176-84. PubMed ID: 26918371 [Abstract] [Full Text] [Related]
16. Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population. Wang XH, Wang FR, Tang YF, Zou HZ, Zhao YQ. Genet Mol Res; 2014 Jul 04; 13(3):5048-54. PubMed ID: 25061729 [Abstract] [Full Text] [Related]
17. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC. Hong MJ, Choi YY, Jang JA, Jung HJ, Lee SY, Lee WK, Yoo SS, Lee J, Cha SI, Kim CH, Lee E, Jeon HS, Son JW, Park JY. J Thorac Oncol; 2013 Jun 04; 8(6):703-10. PubMed ID: 23470291 [Abstract] [Full Text] [Related]
19. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Kim WH, Min KT, Jeon YJ, Kwon CI, Ko KH, Park PW, Hong SP, Rim KS, Kwon SW, Hwang SG, Kim NK. Gene; 2012 Aug 01; 504(1):92-7. PubMed ID: 22583825 [Abstract] [Full Text] [Related]
20. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Guan X, Sturgis EM, Song X, Liu Z, El-Naggar AK, Wei Q, Li G. Cancer Lett; 2013 Apr 28; 330(2):233-40. PubMed ID: 23219900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]